201 related articles for article (PubMed ID: 21674561)
1. Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees.
Barth H; Rybczynska J; Patient R; Choi Y; Sapp RK; Baumert TF; Krawczynski K; Liang TJ
Hepatology; 2011 Oct; 54(4):1135-48. PubMed ID: 21674561
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees.
Nascimbeni M; Mizukoshi E; Bosmann M; Major ME; Mihalik K; Rice CM; Feinstone SM; Rehermann B
J Virol; 2003 Apr; 77(8):4781-93. PubMed ID: 12663785
[TBL] [Abstract][Full Text] [Related]
3. Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain.
Bukh J; Thimme R; Meunier JC; Faulk K; Spangenberg HC; Chang KM; Satterfield W; Chisari FV; Purcell RH
J Virol; 2008 Aug; 82(16):8183-95. PubMed ID: 18550671
[TBL] [Abstract][Full Text] [Related]
4. Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge.
Major ME; Mihalik K; Puig M; Rehermann B; Nascimbeni M; Rice CM; Feinstone SM
J Virol; 2002 Jul; 76(13):6586-95. PubMed ID: 12050371
[TBL] [Abstract][Full Text] [Related]
5. Lack of protective immunity against reinfection with hepatitis C virus.
Farci P; Alter HJ; Govindarajan S; Wong DC; Engle R; Lesniewski RR; Mushahwar IK; Desai SM; Miller RH; Ogata N
Science; 1992 Oct; 258(5079):135-40. PubMed ID: 1279801
[TBL] [Abstract][Full Text] [Related]
6. Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees.
Elmowalid GA; Qiao M; Jeong SH; Borg BB; Baumert TF; Sapp RK; Hu Z; Murthy K; Liang TJ
Proc Natl Acad Sci U S A; 2007 May; 104(20):8427-32. PubMed ID: 17485666
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins.
Dahari H; Feinstone SM; Major ME
Gastroenterology; 2010 Sep; 139(3):965-74. PubMed ID: 20621699
[TBL] [Abstract][Full Text] [Related]
8. Innate and adaptive immune responses in HCV infections.
Heim MH; Thimme R
J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
[TBL] [Abstract][Full Text] [Related]
9. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
[TBL] [Abstract][Full Text] [Related]
10. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection.
Bassett SE; Guerra B; Brasky K; Miskovsky E; Houghton M; Klimpel GR; Lanford RE
Hepatology; 2001 Jun; 33(6):1479-87. PubMed ID: 11391537
[TBL] [Abstract][Full Text] [Related]
11. Immune system control of hepatitis C virus infection.
Stuart JD; Salinas E; Grakoui A
Curr Opin Virol; 2021 Feb; 46():36-44. PubMed ID: 33137689
[TBL] [Abstract][Full Text] [Related]
12. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.
Forns X; Payette PJ; Ma X; Satterfield W; Eder G; Mushahwar IK; Govindarajan S; Davis HL; Emerson SU; Purcell RH; Bukh J
Hepatology; 2000 Sep; 32(3):618-25. PubMed ID: 10960458
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.
Osburn WO; Fisher BE; Dowd KA; Urban G; Liu L; Ray SC; Thomas DL; Cox AL
Gastroenterology; 2010 Jan; 138(1):315-24. PubMed ID: 19782080
[TBL] [Abstract][Full Text] [Related]
14. A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.
Folgori A; Capone S; Ruggeri L; Meola A; Sporeno E; Ercole BB; Pezzanera M; Tafi R; Arcuri M; Fattori E; Lahm A; Luzzago A; Vitelli A; Colloca S; Cortese R; Nicosia A
Nat Med; 2006 Feb; 12(2):190-7. PubMed ID: 16462801
[TBL] [Abstract][Full Text] [Related]
15. Evidence for protection against chronic hepatitis C virus infection in chimpanzees by immunization with replicating recombinant vaccinia virus.
Youn JW; Hu YW; Tricoche N; Pfahler W; Shata MT; Dreux M; Cosset FL; Folgori A; Lee DH; Brotman B; Prince AM
J Virol; 2008 Nov; 82(21):10896-905. PubMed ID: 18753204
[TBL] [Abstract][Full Text] [Related]
16. Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee.
Youn JW; Park SH; Lavillette D; Cosset FL; Yang SH; Lee CG; Jin HT; Kim CM; Shata MT; Lee DH; Pfahler W; Prince AM; Sung YC
Hepatology; 2005 Dec; 42(6):1429-36. PubMed ID: 16317673
[TBL] [Abstract][Full Text] [Related]
17. The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serologic responses measured with first- and second-generation assays and relationship to HCV viremia.
Farci P; London WT; Wong DC; Dawson GJ; Vallari DS; Engle R; Purcell RH
J Infect Dis; 1992 Jun; 165(6):1006-11. PubMed ID: 1374781
[TBL] [Abstract][Full Text] [Related]
18. A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.
Swadling L; Capone S; Antrobus RD; Brown A; Richardson R; Newell EW; Halliday J; Kelly C; Bowen D; Fergusson J; Kurioka A; Ammendola V; Del Sorbo M; Grazioli F; Esposito ML; Siani L; Traboni C; Hill A; Colloca S; Davis M; Nicosia A; Cortese R; Folgori A; Klenerman P; Barnes E
Sci Transl Med; 2014 Nov; 6(261):261ra153. PubMed ID: 25378645
[TBL] [Abstract][Full Text] [Related]
19. Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development.
Alvarez-Lajonchere L; Dueñas-Carrera S
Int Rev Immunol; 2012 Jun; 31(3):223-42. PubMed ID: 22587022
[TBL] [Abstract][Full Text] [Related]
20. Immune and non-immune responses to hepatitis C virus infection.
Sun J; Rajsbaum R; Yi M
World J Gastroenterol; 2015 Oct; 21(38):10739-48. PubMed ID: 26478666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
